Severe Eosinophilic Asthma and Aspirin-Exacerbated Respiratory Disease Associated to Eosinophilic Gastroenteritis Treated With Mepolizumab: A Case Report

Allergy, Asthma and Clinical Immunology - United Kingdom
doi 10.1186/s13223-020-00423-3
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Patients With Severe Eosinophilic Asthma Treated With Mepolizumab: Results From Our Clinical Practice

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Mepolizumab for Severe Refractory Eosinophilic Asthma: Evidence to Date and Clinical Potential

Therapeutic Advances in Chronic Disease
Medicine
2016English

Real-World Safety of Treatment With Mepolizumab and Reslizumab in Patients With Severe Eosinophilic Asthma

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Eosinophilic Gastroenteritis Associated With Rheumatoid Arthritis

Turkish Journal of Rheumatology
2011English

Severe Eosinophilic Asthma: A Roadmap to Consensus

European Respiratory Journal
MedicinePulmonaryRespiratory Medicine
2017English

Prs55 - Cost-Effectiveness of Mepolizumab in Severe Eosinophilic Asthma Patients in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Eosinophilic Gastroenteritis in an Immunosuppressed Patient: A Case Report

International Journal of Advances in Medicine
2018English

Eosinophilic Gastroenteritis and Related Eosinophilic Disorders

Gastroenterology Clinics of North America
Gastroenterology
2014English

Eosinophilic Gastroenteritis

2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy